-$72,000
Value of Insider Transactions in the last 2 years

Insider Transactions

Name Transaction Date Sold / Bought Shares Price Value
Warren EricMay 17, 2024Sell192$2.483$480
Warren EricSep 20, 2023Sell742$1.245$920
Warren EricAug 18, 2023Sell243$1.414$340
Warren EricJul 19, 2023Sell106$1.585$170
Warren EricJun 21, 2023Sell603$1.483$890
Warren EricMay 17, 2023Sell219$1.624$360
CARROLL J MARTINMay 11, 2023Buy23,091$1.5714$36,000
CARROLL J MARTINMay 10, 2023Buy8,409$1.4919$13,000
ROCAMBOLI STEPHENMay 10, 2023Buy8,111$1.495$12,000
Koenig Sheldon L.May 9, 2023Buy20,000$1.2596$25,000
Looker BenjaminApr 19, 2023Sell1,290$1.272$1,600
Warren EricApr 19, 2023Sell115$1.278$150
Foody Joanne M.Apr 19, 2023Sell938$1.271$1,200
Foody Joanne M.Mar 17, 2023Sell3,808$1.7819$6,800
Koenig Sheldon L.Mar 17, 2023Sell6,999$1.783$12,000
Warren EricMar 17, 2023Sell526$1.7823$940
Warren EricMar 7, 2023Sell5,090$5.055$26,000
Koenig Sheldon L.Mar 7, 2023Sell5,441$5.056$28,000
Foody Joanne M.Mar 7, 2023Sell3,884$5.065$20,000
Looker BenjaminJan 18, 2023Sell6,347$6.996$44,000
Foody Joanne M.Jan 18, 2023Sell1,191$6.985$8,300
Foody Joanne M.Oct 18, 2022Sell942$7.688$7,200
Warren EricOct 18, 2022Sell107$7.69$820
Koenig Sheldon L.Sep 19, 2022Sell3,394$6.938$24,000
Warren EricSep 19, 2022Sell255$6.921$1,800
Warren EricAug 31, 2022Buy1,000$7.46$7,500
Warren EricAug 17, 2022Sell199$6.815$1,400
Koenig Sheldon L.Aug 5, 2022Buy8,606$5.8041$50,000
Foody Joanne M.Jul 19, 2022Sell3,901$6.55$26,000
Warren EricJul 19, 2022Sell431$6.582$2,800

What's the latest insider transaction for Esperion Therapeutics?

The most recent insider transaction for Esperion Therapeutics was conducted by Warren Eric, who sold 192 shares on May 17, 2024 at a price of $2.48 per share.

Which insider bought the most ESPR stock over the last two years?

Koenig Sheldon L. has bought the most ESPR stock in the last 2 years, with a total value of $75,000.

Which insider has sold the most ESPR stock over the last two years?

Foody Joanne M. has sold the most ESPR stock in the last 2 years, with a total value of $69,000.

What is the total value of insider transactions for Esperion Therapeutics (ESPR) in the last 2 years?

The total value of insider transactions for Esperion Therapeutics in the last 2 years is negative, amounting to -$72,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

How do insider transactions over the last 2 years reflect on Esperion Therapeutics' market confidence?

Over the last 2 years, insider transactions for Esperion Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.

Why is monitoring insider trading activity important for investors?

Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.